12 Results

People

  1. Kumar
    Kumar
  2. Younes
    Younes
  3. Zelenetz
    Zelenetz
  4. Hamlin
    Hamlin
  5. Matasar
    Matasar
  6. Moskowitz
    Moskowitz
  7. Moskowitz
    Moskowitz
  8. Straus
    Straus
  9. Gerecitano
    Gerecitano
  10. Horwitz
    Horwitz

Groups

  1. Center for Hematologic Malignancies (12)
  2. Department of Medicine (12)
  3. Hematologic Malignancies, Division of (12)
  4. Lymphoma (12)
  5. Epidemiology and Biostatistics (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)
  7. Survivorship Research (6)
  8. Biostatistics Service (5)
  9. Bone Marrow Transplant (4)
  10. Molecular Imaging and Therapy Service (4)
  1. "cancer survival"
  2. "Anita Kumar"
Formats
  1. Journal Article (11)
  2. Review (1)
Groups
  1. Center for Hematologic Malignancies (12)
  2. Department of Medicine (12)
  3. Hematologic Malignancies, Division of (12)
  4. Lymphoma (12)
  5. Epidemiology and Biostatistics (6)
  6. Executive Committee, Center for Hematologic Malignancies (6)

More Groups

People
  1. Anita Kumar (12)
  2. Anas Younes (6)
  3. Andrew Zelenetz (6)
  4. Alison Moskowitz (5)
  5. Craig Moskowitz (5)
  6. David Straus (5)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (1)

More Years

Publications
  1. Blood Advances (3)
  2. Blood (2)
  3. Leukemia and Lymphoma (2)
  4. Blood Cancer Journal (1)
  5. Blood Reviews (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Taylor & Francis Group (2)
  3. American Association for Cancer Research (1)
  4. Churchill Livingstone (1)
  5. John Wiley & Sons (1)
  6. Nature Publishing Group (1)

More Publishers

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
    Journal Article

    Villa, D.; Jiang, A.; Visco, C.; Crosbie, N.; McCulloch, R.; Buege, M. J.; Kumar, A.; Bond, D. A.; Paludo, J.; Maurer, M. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
    Journal Article

    Sawalha, Y.; Goyal, S.; Switchenko, J. M.; Romancik, J. T.; Kamdar, M.; Greenwell, I. B.; Hess, B. T.; Isaac, K. M.; Portell, C. A.; Garcia, A. M.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Targeting the immune microenvironment in mantle cell lymphoma: Implications for current and emerging therapies
    Review

    Qualls, D.; Kumar, A.; Epstein-Peterson, Z. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma
    Journal Article

    Mayerhoefer, M. E.; Riedl, C. C.; Kumar, A.; Gibbs, P.; Weber, M.; Tal, I.; Schilksy, J.; Schòˆder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Devlin, S. M.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save